TIDMIHC

RNS Number : 5082D

Inspiration Healthcare Group PLC

22 June 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Strengthens Board with the Appointment of Marlou Janssen-Counotte as Non-Executive Director

Marlou brings extensive international commercial experience

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the appointment of Louise Marie ("Marlou") Janssen-Counotte as a Non-executive Director of the Company, with effect from 21 June 2023.

Marlou, a Dutch national, brings a wealth of experience gained in internationally recognised medical technology companies including Philips, Biotronik, St Jude Medical and Medtronic, in which she has held senior commercial leadership roles. Marlou has extensive international experience and has lived and worked in the USA. She is currently also a non-executive director of Acarix AB (a Stockholm Nasdaq First North Premier Growth Market listed company).

Mark Abrahams, Chairman of Inspiration Healthcare said : "I am delighted to welcome Marlou to our Board, her extensive international experience and commercial insights as a health tech leader will be beneficial to the Company as we continue to deliver our growth strategy and strengthen our position as a leading specialist innovative medical technology company focused on neonatal intensive care."

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Louise Marie Janssen-Counotte (aged 58 years) holds/has held the following directorships/partnerships in the last five years:

 
 Current directorships/partnerships   Previous directorships/partnerships 
                                       (last five years) 
 Acarix AB                            Biotronik Inc. 
  Acarix A/S                           EPD Medco B.V. 
  Field Medical Inc.                   ABI Intel Ltd

Marlou Janssen-Counotte holds no ordinary shares in the Company.

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

 
 Inspiration Healthcare Group                                         Tel: +44 (0)330 175 0000 
  plc 
 Neil Campbell, Chief Executive 
  Officer 
 
 Liberum (Nominated Adviser &                                         Tel: +44 (0)20 3100 2000 
  Broker) 
 Phil Walker, Richard Lindley, 
  William Hall, Will King 
 
 Walbrook PR Ltd (Media and Investor                                  Tel: +44 (0)20 7933 8780 
  Relations) 
 Anna Dunphy/Stephanie Cuthbert

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products. The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.

With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex). The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOADFLFLXQLLBBB

(END) Dow Jones Newswires

June 22, 2023 02:00 ET (06:00 GMT)

Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Inspiration Healthcare.
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Inspiration Healthcare.